Status:

COMPLETED

Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg

Lead Sponsor:

Cardiovascular Clinical Sciences Inc

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Chronic Heart Failure

Eligibility:

All Genders

18-90 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to compare dosing compliance between study patients taking controlled release carvedilol once a day, and study patients taking immediate release carvedilol (Coreg) twice a...

Detailed Description

Study Further Study Details: Primary outcome: pill-taking compliance (total doses taken versus total doses prescribed) Expected Total Enrollment: 400 subjects at 56 study sites in the U.S. Study St...

Eligibility Criteria

Inclusion

  • Ability to read English
  • Stable symptoms of mild to severe heart failure
  • Stable medical regimen for heart failure
  • On a stable dose of Coreg for at least 2 months
  • LVEF ≤40% within the previous 24 months

Exclusion

  • Uncorrected obstructive or regurgitant valve disease
  • Complex congenital heart disease
  • Recent ICD or pacemaker placement
  • Recent coronary artery bypass surgery or stroke
  • Candidate for heart transplanct within 5 months of study start
  • Present or planned use of MAO inhibitors, alfpha-blockers, combined alpha-beta blockers, any Class I/II anti-arrythmnic agents, (amiodarone may be used if ≤ 200mg/day). Use of intravenous vasodilator/inotropic agents.

Key Trial Info

Start Date :

October 1 2005

Trial Type :

INTERVENTIONAL

End Date :

July 1 2006

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT00272805

Start Date

October 1 2005

End Date

July 1 2006

Last Update

February 18 2013

Active Locations (54)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 14 (54 locations)

1

The Heart Group

Mobile, Alabama, United States, 36608

2

Radiant Research

Sierra Vista, Arizona, United States, 85635

3

Cardiology Consultants of Orange County

Anaheim, California, United States, 92801

4

Access Clinical Trials

Beverly Hills, California, United States, 90210